Sodium

Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 47, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
Patient, Medical Subject Headings, Marketing, Diplopia, Agency, INN, Risk, ATC, International, Population, Headache, Ageing, Nausea, Sodium, Brain, Language, Mouth, Seizure, Dizziness, European Medicines Agency, Nervous system, Tablet, Select, Safety, Generalized tonic–clonic seizure, Anatomy, IIA, Carbamazepine, Medical device

Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 47, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 47, Status: Authorised

Human medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 19, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
Blood pressure, Urine, Patient, Medical Subject Headings, Heart failure, Marketing, Nitrosamine, Quality of life, Kidney, Sacubitril, INN, Pediatrics, Natriuresis, Death, Valsartan, Woman, Failure, Hypotension, ATC, System, Blood, International, Sodium, European, Disease, Angioedema, Diabetes, Tissue, Profile, Language, Ageing, Mouth, Heart, Enalapril, Hyperkalemia, Angiotensin, Water, European Medicines Agency, ACE, Tablet, Select, Liver disease, Anatomy, Medicine, Fibrosis, IIA, Science, Pharmaceutical industry

Human medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 19, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 19, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
Blood pressure, Urine, Patient, Medical Subject Headings, Heart failure, Marketing, Nitrosamine, Quality of life, Kidney, Sacubitril, INN, Pediatrics, Natriuresis, Death, Valsartan, Woman, Failure, Hypotension, ATC, System, Blood, International, Sodium, European, Disease, Angioedema, Tissue, Profile, Diabetes, Language, Ageing, Heart, Enalapril, Angiotensin, Hyperkalemia, Water, European Medicines Agency, ACE, Tablet, Select, Liver disease, Anatomy, Medicine, Fibrosis, IIA, Science, Medical device

Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 19, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Inhixa, enoxaparin sodium, Date of authorisation: 15/09/2016, Revision: 26, Status: Authorised

Retrieved on: 
Tuesday, January 2, 2024
Medical Subject Headings, Marketing, Liver, Coronary thrombosis, INN, Risk, Pulmonary embolism, STEMI, ATC, DVT, Unstable angina, Bleeding, International, ASA, Myocardial infarction, Antithrombin, Language, Heart, Stroke, European Medicines Agency, Infection, Extracorporeal, Sodium oxide, Rheumatology, Select, Chest pain, Patient, Aspirin, Vein, Safety, Anatomy, Medicine, Leg, Deep vein thrombosis, IIA, Sodium, Skin, Birth control

Human medicines European public assessment report (EPAR): Inhixa, enoxaparin sodium, Date of authorisation: 15/09/2016, Revision: 26, Status: Authorised

Key Points: 


Human medicines European public assessment report (EPAR): Inhixa, enoxaparin sodium, Date of authorisation: 15/09/2016, Revision: 26, Status: Authorised

Standard Lithium Provides Comprehensive Results of Its Fully Optimized and Proven DLE Process

Retrieved on: 
Monday, November 20, 2023
Lithium, Dorado, Plant, DLE, Demonstration plant, Potassium, Magnesium, LSS, FRA, Calcium, Knowledge, SLI, Lithium chloride, Boron, Sodium

EL DORADO, Ark., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today shared detailed performance results from its Direct Lithium Extraction (DLE) process at its Demonstration Plant (Plant) near El Dorado, Arkansas.

Key Points: 
  • EL DORADO, Ark., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today shared detailed performance results from its Direct Lithium Extraction (DLE) process at its Demonstration Plant (Plant) near El Dorado, Arkansas.
  • Standard Lithium's Demonstration Plant is the only truly large-scale, continuously operating DLE plant in North America.
  • Both studies incorporate the LiPROTM LSS (DLE) process developed in collaboration with Koch Technology Solutions, LLC (“KTS”).
  • Lithium Recovery Efficiency: During a representative period of performance over July and August 2023, the LiPROTM LSS (DLE) process achieved an average lithium recovery of 96.1% from the continuous incoming brine flow.

Standard Lithium Provides Comprehensive Results of Its Fully Optimized and Proven DLE Process

Retrieved on: 
Monday, November 20, 2023
Lithium, Dorado, Plant, DLE, Demonstration plant, Potassium, Magnesium, LSS, FRA, Calcium, Knowledge, SLI, Lithium chloride, Boron, Sodium

EL DORADO, Ark., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today shared detailed performance results from its Direct Lithium Extraction (DLE) process at its Demonstration Plant (Plant) near El Dorado, Arkansas.

Key Points: 
  • EL DORADO, Ark., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today shared detailed performance results from its Direct Lithium Extraction (DLE) process at its Demonstration Plant (Plant) near El Dorado, Arkansas.
  • Standard Lithium's Demonstration Plant is the only truly large-scale, continuously operating DLE plant in North America.
  • Both studies incorporate the LiPROTM LSS (DLE) process developed in collaboration with Koch Technology Solutions, LLC (“KTS”).
  • Lithium Recovery Efficiency: During a representative period of performance over July and August 2023, the LiPROTM LSS (DLE) process achieved an average lithium recovery of 96.1% from the continuous incoming brine flow.

Vast and Nabors Energy Transition Corp. Announce Closing of Business Combination, Establishing Public Concentrated Solar Thermal Power Company

Retrieved on: 
Monday, December 18, 2023
Green Technology, Alternative Energy, Energy, Environment, Utilities, Nabors Industries, Partnership, NETC, Steam, Multimedia, Business analyst, CSP, Sodium, NBR, Electricity, VS1, SM1, USD, Element, Letter, Carbon, Renewable energy

Vast Renewables Limited (“Vast” or the “Company”), a renewable energy company specialising in concentrated solar thermal power (“CSP”) energy systems that generate zero-carbon, utility-scale electricity and industrial process heat, today announced the completion of its business combination (the “Business Combination”) with Nabors Energy Transition Corp. (“NETC”), an affiliate of Nabors Industries Ltd. (“Nabors”) (NYSE: NBR).

Key Points: 
  • Vast Renewables Limited (“Vast” or the “Company”), a renewable energy company specialising in concentrated solar thermal power (“CSP”) energy systems that generate zero-carbon, utility-scale electricity and industrial process heat, today announced the completion of its business combination (the “Business Combination”) with Nabors Energy Transition Corp. (“NETC”), an affiliate of Nabors Industries Ltd. (“Nabors”) (NYSE: NBR).
  • Grants and other support from the Australian and German governments, along with partnerships with leading corporations, demonstrate growing support for Vast’s breakthrough solution.
  • Since the announcement of the proposed Business Combination on February 14, 2023, Vast has continued to make significant strides, both commercially and technologically.
  • Over the course of the past year, Vast has achieved a number of project updates and partnership agreements.

Kanazawa University research: Sodium channel investigation

Retrieved on: 
Wednesday, December 20, 2023
Noetics, Sodium, Map, Kanazawa University, Wakayama Medical University, The central science, AFM, Arcobacter, B cell, Cell membrane, Observation, Electric potential, Nature, Arcobacter butzleri, Cell, Nature Communications, Neuron, Microscope

KANAZAWA, Japan, Dec. 19, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Nature Communications a high-speed atomic force microscopy study of the structural dynamics of sodium ion channels in cell membranes.

Key Points: 
  • KANAZAWA, Japan, Dec. 19, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Nature Communications a high-speed atomic force microscopy study of the structural dynamics of sodium ion channels in cell membranes.
  • An important open question is whether the voltage sensor domains dissociate from the pore domains when the channel closes.
  • One is the sodium channel of a particular bacterium (Arcobacter butzleri), the other two are mutants thereof.
  • In recent years, researchers at Kanazawa University have further developed HS-AFM so that it can be applied for studying biochemical molecules and biomolecular processes in real-time.

Kanazawa University research: Sodium channel investigation

Retrieved on: 
Wednesday, December 20, 2023
Noetics, Sodium, Map, Kanazawa University, Wakayama Medical University, The central science, AFM, Arcobacter, B cell, Cell membrane, Observation, Electric potential, Nature, Arcobacter butzleri, Cell, Nature Communications, Neuron, Microscope

KANAZAWA, Japan, Dec. 19, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Nature Communications a high-speed atomic force microscopy study of the structural dynamics of sodium ion channels in cell membranes.

Key Points: 
  • KANAZAWA, Japan, Dec. 19, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in Nature Communications a high-speed atomic force microscopy study of the structural dynamics of sodium ion channels in cell membranes.
  • An important open question is whether the voltage sensor domains dissociate from the pore domains when the channel closes.
  • One is the sodium channel of a particular bacterium (Arcobacter butzleri), the other two are mutants thereof.
  • In recent years, researchers at Kanazawa University have further developed HS-AFM so that it can be applied for studying biochemical molecules and biomolecular processes in real-time.

UC San Diego spin-off company receives MWh-scale purchase orders of their advanced sodium-ion batteries

Retrieved on: 
Tuesday, December 19, 2023
Kilowatt-hour, Multimedia, Tin, Electron, Research, University of California, LFP, ESS, SAN, Battery, University, ACCESS, Pritzker School, Doctor of Philosophy, Silicon, Sodium, Electric battery

SAN DIEGO, Dec. 19, 2023 /PRNewswire/ -- UNIGRID Battery, a University of California, San Diego spin-off startup company, announces that it has received its first commercial MWh-scale purchase orders for their advanced sodium ion batteries.

Key Points: 
  • SAN DIEGO, Dec. 19, 2023 /PRNewswire/ -- UNIGRID Battery, a University of California, San Diego spin-off startup company, announces that it has received its first commercial MWh-scale purchase orders for their advanced sodium ion batteries.
  • Due to this combination of properties, sodium ion batteries are emerging as the next big wave in battery technology.
  • Third party testing and validation on the advanced sodium ion batteries has been completed, and UNIGRID is on track to deliver MWh quantities of its advanced sodium ion batteries to customers in 2024.
  • The team is currently ramping up production in San Diego, California, in order to meet the rapidly growing interest and demand for their sodium-ion batteries.